Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease.
Détails
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_7D6E611F997B
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Lettre (letter): communication adressée à l'éditeur.
Collection
Publications
Institution
Titre
Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease.
Périodique
Critical care
ISSN
1466-609X (Electronic)
ISSN-L
1364-8535
Statut éditorial
Publié
Date de publication
08/06/2020
Peer-reviewed
Oui
Volume
24
Numéro
1
Pages
318
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Publication Status: epublish
Mots-clé
COVID-19, Coronavirus Infections/drug therapy, Humans, Mineralocorticoid Receptor Antagonists/therapeutic use, Pandemics, Pneumonia, Viral/drug therapy, Severity of Illness Index, Spironolactone/therapeutic use
Pubmed
Web of science
Open Access
Oui
Création de la notice
10/06/2020 15:02
Dernière modification de la notice
08/08/2024 6:36
Données d'usage
